Effect of Fucoxanthin on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion-Reference-Cited by-同舟云学术

Effect of Fucoxanthin on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion

Published:2023-07-01 Issue:7 Volume:26 Page:521-527
ISSN:1096-620X
Container-title:Journal of Medicinal Food
language:en
Short-container-title:Journal of Medicinal Food

Author:

López-Ramos Armando¹^ORCID,González-Ortiz Manuel¹²,Martínez-Abundis Esperanza¹²,Pérez-Rubio Karina G.¹²

Affiliation:

1. Institute of Experimental and Clinical Therapeutics, Department of Physiology, Health Science University Center, University of Guadalajara, Guadalajara, Jalisco, Mexico.

2. Health Biomedical Research Center, Guadalajara, Jalisco, Mexico.

Publisher

Mary Ann Liebert Inc

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

https://www.liebertpub.com/doi/pdf/10.1089/jmf.2022.0103

Reference27 articles.

1. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds

2. The Global Epidemic of the Metabolic Syndrome

3. The metabolic syndrome—a new worldwide definition

4. Advances in Studies on the Pharmacological Activities of Fucoxanthin

5. Anti-Obesity Activity of the Marine Carotenoid Fucoxanthin

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Supplementation with a Microalgae Extract from Phaeodactylum tricornutum Containing Fucoxanthin on Cognition and Markers of Health in Older Individuals with Perceptions of Cognitive Decline;Nutrients;2024-09-05

2. Recent Advances in the Therapeutic Potential of Carotenoids in Preventing and Managing Metabolic Disorders;Plants;2024-06-07

3. Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes;Marine Drugs;2024-05-03